Yüklüyor......
Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching
BACKGROUND: Risperidone long-acting injection (RLAI) is increasingly being switched to paliperidone palmitate (PP) because of several benefits. However, this switching is not always successful. METHODS: We examined patient profiles following discontinuation of PP after switching from RLAI. We collec...
Kaydedildi:
| Yayımlandı: | Psychopharmacol Bull |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MedWorks Media Global
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5044467/ https://ncbi.nlm.nih.gov/pubmed/27738379 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|